Actively Recruiting
Biobank to Identify Diagnostic and Treatment Biomarkers in Early and Advanced Lung Cancer
Led by University Hospital, Toulouse · Updated on 2026-03-19
3000
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are collecting clinical and biological data from patients with chronic respiratory diseases, focusing on those with lung cancer. The study includes two groups one with early-stage lung cancer or large lung nodules needing diagnostic or therapeutic procedures, and another with advanced lung cancer. The goal is to find biomarkers that can help diagnose and guide treatment for lung cancer. Participants will provide various biological samples, such as blood, bronchoalveolar lavage, urine, saliva, and more, depending on their condition. These samples and clinical data will be collected at the start and throughout their usual care visits, for up to 15 years. The study evaluates if less invasive samples can reveal important biomarkers compared to traditional tissue biopsies. During the study, patients will undergo sample collections alongside their regular medical care. Researchers will analyze these samples and clinical information to identify diagnostic, prognostic, and therapeutic biomarkers. The main outcome is building a comprehensive biological collection for lung cancer patients, with ongoing monitoring of biomarkers over time and their relation to tissue biopsy results.
CONDITIONS
Brief Title
Biobank for the Identification of Biomarkers in Lung Cancer (BIRD, Biomarkers in Respiratory Disease)
Research Team
N
Nicolas GUIBERT, MD PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here